People: Sinopharm Tech Holdings Ltd (8156.HK)
Dr. Liu Ta-pei was the Non-Executive Independent Director of the Company. He graduated from National Chung-Hsing University in Taiwan. After graduation, he continued his studies in National Cheng-Chi University, Taiwan and the University of Southern California, U.S.A., and obtained a Master of Science and a MBA degree respectively. He was then conferred his Doctoral degree in public administration from the University of La Verne, U.S.A. and Doctoral degree in Finance from Shanghai University of Finance and Economics. Apart from his strong educational background, Dr. LIU has been active in the financial field for more than 20 years. Dr. LIU is currently an executive director of Huisheng International Holdings Limited, which is listed on the Main Board of the Stock Exchange (Stock code: 1340). He was previously a director of Mega Financial Holdings Company Limited (“Mega Financial Holdings”), which is listed on the Taiwan Stock Exchange Corporation (Stock code: 2886.TW) and also served as the chairman of Mega Securities Co., Ltd, a subsidiary of Mega Financial Holdings. He had also been a director of Global Securities Finance Corporation, Chung Hsing Bills Finance Corporation, and Central Investment Holding Company respectively, and the chairman of Jen Hwa Investment Holding Company. Dr. LIU had served as one of the top management in China Development Industrial Bank, the largest investment bank in Taiwan. He had also been the chief executive officer and an executive director of the Core Pacific-Yamaichi Group in Hong Kong. Dr. LIU was ranked as one of the “Top Ten Intelligent Financial Personnel in Greater China” and he was conferred the “Best Integrity Award” in 2008. He was also granted the honour of “Golden Peak Award of Outstanding Corporation Leaders in Taiwan” in 1998. Dr. LIU is currently a member of Hong Kong Economic Development Commission.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|